NPPB and AL amyloidosis: On the other hand, Palladini et al. confirmed that the reduction of circulating monoclonal chains in patients with AL amyloidosis resulted in a decrease in NT-proBNP concentration and prolonged overall survival, regardless of the size of amyloid deposits in the heart [24].